S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
Log in

NASDAQ:VRTXVertex Pharmaceuticals Price Target & Analyst Ratings

$261.86
-6.87 (-2.56 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$261.30
Now: $261.86
$267.99
50-Day Range
$268.73
MA: $286.16
$303.10
52-Week Range
$165.23
Now: $261.86
$306.08
Volume1.37 million shs
Average Volume1.85 million shs
Market Capitalization$68.21 billion
P/E Ratio33.06
Dividend YieldN/A
Beta0.88

Analyst Ratings

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
29 Wall Street analysts have issued ratings and price targets for Vertex Pharmaceuticals in the last 12 months. Their average twelve-month price target is $295.81, suggesting that the stock has a possible upside of 12.96%. The high price target for VRTX is $340.00 and the low price target for VRTX is $230.00. There are currently 8 hold ratings, 20 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.762.762.762.76
Ratings Breakdown: 0 Sell Rating(s)
8 Hold Rating(s)
20 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
20 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
22 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
19 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $295.81$285.12$276.88$252.41
Price Target Upside: 12.96% upside4.66% downside9.44% upside11.17% upside

Vertex Pharmaceuticals (NASDAQ:VRTX) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Vertex Pharmaceuticals (NASDAQ:VRTX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/31/2020Cantor FitzgeraldBoost Price TargetOverweight$293.00 ➝ $305.00High
7/31/2020SVB LeerinkBoost Price TargetMarket Perform$263.00 ➝ $274.00High
7/31/2020HC WainwrightReiterated RatingBuy$295.00 ➝ $315.00High
7/31/2020Piper SandlerBoost Price TargetOverweight$302.00 ➝ $327.00High
7/20/2020Credit Suisse GroupBoost Price TargetOutperform$298.00 ➝ $328.00High
7/16/2020CowenBoost Price TargetOutperform$265.00 ➝ $300.00Low
7/14/2020Jefferies Financial GroupBoost Price TargetBuy$295.00 ➝ $340.00High
7/8/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight$277.00 ➝ $300.00Medium
7/2/2020Goldman Sachs GroupBoost Price TargetPositive ➝ Conviction-Buy$290.00 ➝ $330.00Low
6/24/2020SunTrust BanksBoost Price TargetBuy$285.00 ➝ $330.00High
6/12/2020CitigroupBoost Price TargetTop Pick ➝ Buy$305.00 ➝ $325.00Low
5/15/2020ArgusBoost Price TargetBuy$270.00 ➝ $320.00High
4/30/2020CfraBoost Price TargetBuy$286.00 ➝ $297.00Low
4/30/2020GuggenheimBoost Price TargetBuy$266.00 ➝ $290.00High
4/30/2020BMO Capital MarketsBoost Price TargetOutperform$279.00 ➝ $283.00High
4/30/2020Stifel NicolausBoost Price TargetBuy$275.00 ➝ $285.00High
4/30/2020OppenheimerBoost Price TargetOutperform$265.00 ➝ $305.00High
4/30/2020JMP SecuritiesBoost Price TargetMarket Outperform$255.00 ➝ $285.00High
4/28/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$250.00 ➝ $260.00High
3/12/2020Wolfe ResearchInitiated CoverageOutperform$282.00High
3/4/2020BarclaysInitiated CoverageOverweight$271.00High
2/2/2020Evercore ISIReiterated RatingHold$270.00Medium
1/31/2020Bank of AmericaReiterated RatingBuy$250.00 ➝ $295.00High
1/31/2020Needham & Company LLCReiterated RatingHoldHigh
1/31/2020JPMorgan Chase & Co.Boost Price TargetOverweight$247.00 ➝ $260.00High
1/31/2020Robert W. BairdDowngradeOutperform ➝ Neutral$210.00 ➝ $230.00High
1/6/2020Piper Jaffray CompaniesBoost Price TargetOverweight$247.00 ➝ $284.00N/A
1/2/2020Raymond JamesDowngradeOutperform ➝ Market PerformLow
11/1/2019Maxim GroupReiterated RatingHoldHigh
3/26/2019William BlairUpgradeMarket Perform ➝ Outperform$183.85Medium
7/26/2018UBS GroupBoost Price TargetNeutral ➝ Neutral$183.00 ➝ $188.00High
12/12/2017Deutsche BankInitiated CoverageBuy$175.00High
9/29/2017DA DavidsonInitiated CoverageBuy$200.00Low
9/29/2017BTIG ResearchInitiated CoverageBuy ➝ Buy$200.00Medium
(Data available from 8/11/2018 forward)
This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.